These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35611008)

  • 1. Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration.
    Ali Said Y; Vanwynsberghe D; Jacob J
    Case Rep Ophthalmol; 2022; 13(1):247-252. PubMed ID: 35611008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration.
    Moisseiev E; Goldstein M; Loewenstein A; Moisseiev J
    Case Rep Ophthalmol; 2010 Aug; 1(1):36-41. PubMed ID: 21369348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Uncommon Aflibercept Side Effect: Full Thickness Macular Hole Formation After Intravitreal Injections in Patients With Pre-existing Vitreomacular Traction.
    Karamitsos A; Sorkou KN; Bhagey J; Hillier RJ; Papastavrou VT
    Cureus; 2021 Jan; 13(1):e12872. PubMed ID: 33633901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full thickness macular hole case after intravitreal aflibercept treatment.
    Oshima Y; Apte RS; Nakao S; Yoshida S; Ishibashi T
    BMC Ophthalmol; 2015 Mar; 15():30. PubMed ID: 25881212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
    Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
    Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aflibercept for neovascular age-related macular degeneration.
    Sarwar S; Clearfield E; Soliman MK; Sadiq MA; Baldwin AJ; Hanout M; Agarwal A; Sepah YJ; Do DV; Nguyen QD
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011346. PubMed ID: 26857947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal aflibercept efficacy in neovascular age-related macular degeneration with suboptimal response to anti-vascular endothelial growth factor-A therapy.
    Monés J; Biarnés M;
    Eur J Ophthalmol; 2020 Sep; 30(5):1082-1090. PubMed ID: 31088111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REOPENING OF MACULAR HOLE AFTER INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Chan EW; Sun V; Chen JC
    Retin Cases Brief Rep; 2020; 14(3):255-259. PubMed ID: 29252912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative and fluorescein angiographic findings of a secondary macular hole associated with age-related macular degeneration treated by pars plana vitrectomy.
    Okamoto T; Shinoda H; Kurihara T; Nagai N; Tsubota K; Ozawa Y
    BMC Ophthalmol; 2014 Sep; 14():114. PubMed ID: 25270019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab.
    Nudleman E; Wolfe JD; Woodward MA; Yonekawa Y; Williams GA; Hassan TS
    Clin Ophthalmol; 2016; 10():1053-7. PubMed ID: 27354759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection frequency and anatomic outcomes 1 year following conversion to aflibercept in patients with neovascular age-related macular degeneration.
    Messenger WB; Campbell JP; Faridi A; Shippey L; Bailey ST; Lauer AK; Flaxel CJ; Hwang TS
    Br J Ophthalmol; 2014 Sep; 98(9):1205-7. PubMed ID: 24795334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration.
    Sizmaz S; Esen E; Isik-Ericek P; Demircan N
    Clin Exp Optom; 2022 Jan; 105(1):55-60. PubMed ID: 33719869
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration.
    Park DH; Sun HJ; Lee SJ
    Int Ophthalmol; 2017 Oct; 37(5):1205-1214. PubMed ID: 27826933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal and Choroidal Changes after Anti Vascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration.
    Kim SW; Woo JE; Yoon YS; Lee S; Woo JM; Min JK
    Curr Pharm Des; 2019; 25(2):184-189. PubMed ID: 30892159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerating subretinal fluid in the treatment of neovascular age-related macular degeneration with intravitreal aflibercept.
    Yildiz D; Cakir A; Erden B; Bolukbasi S; Erdenöz S; Elcioglu MN
    Ther Adv Ophthalmol; 2021; 13():25158414211022874. PubMed ID: 34164606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meticulous multimodal analysis of aflibercept therapy for submacular vascularized pigment epithelial detachment associated with neovascular AMD in a prospective case series, the EVEN study.
    Chan CK; Sarraf D; Abraham P; Lalezary M; Lin SG; Chen X; Nittala MG; Sadda S
    Am J Ophthalmol Case Rep; 2020 Dec; 20():100916. PubMed ID: 33024885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.
    Bakall B; Folk JC; Boldt HC; Sohn EH; Stone EM; Russell SR; Mahajan VB
    Am J Ophthalmol; 2013 Jul; 156(1):15-22.e1. PubMed ID: 23706500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration.
    Hirata A; Hayashi K; Murata K; Nakamura KI
    Am J Ophthalmol Case Rep; 2018 Mar; 9():14-17. PubMed ID: 29468210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration.
    Torabi H; Jadidi K; Naderi M
    Oman J Ophthalmol; 2018; 11(3):277-279. PubMed ID: 30505124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switch to aflibercept in the treatment of neovascular age-related macular degeneration: 30-month results.
    Ertan E; Doğan M; Polat O; Efe N; Akdoğan M; İnan S; Duman R; Duman R
    Arq Bras Oftalmol; 2021; 84(3):225-229. PubMed ID: 33567025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.